Organ-On-Chip Market is expected to grow at a CAGR of 31.14% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, The global Organ-On-Chip market size is expected to reach $3.87 Billion in 2023 growing at a CAGR of 31.14% from 2023 to 2033. Organ-on-chip refers to a technology that involves the creation of microscale devices designed to simulate the structure and function of specific human organs. These chips, often made from materials like silicone or polymers, contain tiny channels and chambers lined with living human cells. The goal is to replicate the physiological and mechanical aspects of organs, allowing researchers to study biological processes, test drug responses, and understand diseases in a more accurate and controlled in vitro environment. Organ-on-chip technology holds promise for advancing drug development, toxicity testing, and personalized medicine by providing a more realistic and efficient platform for studying human biology compared to traditional cell cultures or animal models.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021663

The Organ-On-Chip market is primarily driven by the increasing demand for more physiologically relevant in vitro models for drug development and disease research, offering improved accuracy and efficiency in mimicking human organ functions.

Key Players
Some of the major Organ-On-Chip Market players holding high market shares include Emulate, Inc., Insphero AG, Tara Biosystems, Nortis Inc., Elveflow, CN Bio Innovations Limited. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include AxoSim Technologies LLC, Mimetas B.V., Organovo Holdings, Inc., BICO Group AB(Visikol).

Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021663

Segmental Analysis
Based on the Type, the Organ-On-Chip market is segmented into Heart on chip, Human on chip, Intestine on chip, Kidney on chip, Liver on chip, Lung on chip. The dominance of the Heart on chip segment in the Organ-On-Chip market is attributed to its critical role in cardiovascular drug testing, disease modeling, and toxicity studies, addressing a key area of pharmaceutical research and fostering advancements in precision medicine.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.